Hospital Universitario Basurto
- Address
- lock Available on a paid plan
Hematology and Blood Disorders
The Hematología department at Hospital Universitario Basurto is active in studies of hematic and lymphatic diseases, with a strong focus on cancers and immune-related blood conditions. Research here includes acute myeloid leukemia, chronic myeloid leukemia, paroxysmal nocturnal hemoglobinuria, and peripheral T-cell lymphoma, reflecting an effort to improve treatment options and long-term disease control.
- Testing new therapies for blood cancers and rare hematologic disorders
- Evaluating treatment effectiveness in leukemia and lymphoma
- Studying immune-based approaches for blood-related diseases
These trials aim to expand options for patients with complex blood diseases while supporting safer and more effective care.
Breast and Gynecologic Oncology
One of the most prominent research areas at this site is neoplasms, especially breast cancer. Trials cover early and advanced disease, including HER2-positive, HER2-negative, and triple-negative breast cancer, as well as locoregional recurrence and metastatic disease. The research is centered on improving outcomes with newer cancer therapies and refining treatment strategies for different tumor subtypes.
- Testing targeted and antibody-based treatments for breast cancer
- Evaluating therapies for high-risk, recurrent, and metastatic disease
- Studying ways to improve survival and reduce relapse
At Hospital Universitario Basurto, this oncology portfolio shows a strong commitment to personalized cancer care.
Lung Cancer and Thoracic Oncology
Clinical research in respiratory tract diseases includes a substantial number of studies in non-small cell lung cancer and small cell lung cancer. The trials address newly diagnosed, locally advanced, and metastatic disease, with attention to biomarker-driven subgroups such as KRASG12C and HER2 alterations. The overall goal is to improve response rates, disease control, and long-term outcomes in lung cancer.
- Testing new immunotherapy and targeted treatment options
- Improving care for advanced and resectable lung cancer
- Exploring biomarker-guided approaches to treatment selection
This area also includes studies designed to strengthen treatment effectiveness after surgery or chemoradiotherapy.
Autoimmune and Inflammatory Diseases
The site is also highly active in immune system diseases and phenomena and processes related to inflammation. Research includes rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, Sjögren’s syndrome, and giant cell arteritis. These studies are focused on reducing disease activity, easing symptoms, and improving daily functioning for people with chronic autoimmune conditions.
- Evaluating new immune-modulating therapies
- Measuring symptom relief and disease control
- Studying treatment options for difficult-to-manage inflammatory disorders
The research portfolio also includes related conditions affecting nerves and connective tissue, showing broad expertise in inflammatory disease care.
Dermatology and Allergic Conditions
Research in skin and connective tissue diseases includes studies of atopic dermatitis, chronic inducible urticaria, nummular dermatitis, and allergic rhinoconjunctivitis. These trials are designed to test new treatment approaches, improve long-term symptom control, and support better quality of life for patients with persistent allergic and inflammatory skin conditions.
- Testing therapies for moderate-to-severe eczema and related skin diseases
- Evaluating options for chronic itching and urticaria
- Improving control of allergy-driven symptoms
The dermatology program adds important breadth to the clinical research profile of Hospital Universitario Basurto.
Neurology and Neuromuscular Disorders
Studies in nervous system diseases and related immune processes include multiple sclerosis, generalized myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy. The main purpose of these trials is to assess new treatments that may help control symptoms, prevent relapses, and preserve neurological function over time.
- Evaluating therapies for autoimmune nerve and muscle disorders
- Assessing long-term disease control in chronic neurological illness
- Supporting research into improved functional outcomes
These investigations reflect a strong interest in immune-mediated neurological disease at the site.
Cardiovascular, Metabolic, and Renal Research
The trial portfolio also spans cardiovascular diseases, nutritional and metabolic diseases, and kidney-related care. Research includes atherosclerotic cardiovascular disease, spontaneous coronary artery dissection, heart failure, type 2 diabetes, and end-stage kidney disease. These studies seek better ways to prevent complications, improve disease management, and evaluate the effectiveness of newer treatments.
- Testing therapies to reduce cardiovascular events and improve heart health
- Studying glucose control in diabetes
- Evaluating care approaches for kidney disease and dialysis-related needs
This area shows a broad interest in chronic disease management and prevention.
Urologic and Genitourinary Oncology
Another important field is male urogenital diseases and female urogenital diseases, especially bladder cancer, upper tract urothelial carcinoma, and prostate cancer. The studies are aimed at improving treatment effectiveness, supporting surgery-related decision-making, and exploring better options for patients with recurrent, high-risk, or advanced disease.
- Evaluating new treatments for bladder and urinary tract cancers
- Studying approaches for high-risk non-muscle invasive disease
- Assessing treatment strategies in advanced prostate cancer
The research activity here highlights a strong oncology focus beyond breast and lung cancer.
Other Specialized Research Areas
The site also conducts studies in several additional therapeutic areas, including digestive system diseases, eye diseases, musculoskeletal diseases, hormonal diseases, and virus diseases. Examples include idiopathic pulmonary fibrosis, progressive fibrosing interstitial lung disease, transthyretin amyloidosis, and HIV infections, showing a wide-ranging clinical research program that extends beyond its core hematology expertise.
- Testing treatments for rare and chronic multisystem diseases
- Improving long-term safety and symptom control
- Exploring new options across diverse medical specialties
Across these areas, Hospital Universitario Basurto supports research aimed at practical improvements in patient care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 of 22 therapeutic areas and 15 of 229 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 207 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 55 by active trials.
lock +54 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +32 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hospital Universitario Basurto
lock Showing 1 of 163 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A multicenter, double-blind, placebo-controlled, clinical trial to evaluate the efficacy and safety of two concentrations of a mixture of depigmented polymerized allergenic extracts of D. pteronyssinus and D. farinae, in patients suffering from allergic rhinoconjunctivitis with or without controlled asthma | LETI Pharma S.L.U. | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 229 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Paclitaxel | 11 | Unknown | 2018-01-10 | 2026-03-13 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.